Autologous peripheral SCT has largely replaced BMT for the treatment of cancer in both adults and children. Cells are collected by apheresis. The technique has been widely used in France since its ...

The global Apheresis Equipment Market is valued at $2.01 million in 2023 and is projected to reach a value of $2.20 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% from 2024 ...

Risk-stratification technology is evolving in chronic lymphocytic leukemia and can be used to guide treatment decisions and direct patients to clinical trials. A report examines a newly created role ...